Navigation Links
ARIUS recognized for entrepreneurial excellence
Date:4/7/2008

Dr. David S. Young awarded "Most Innovative" award by the Association of

Chinese Canadian Entrepreneurs

TORONTO, April 7 /PRNewswire-FirstCall/ - ARIUS Research Inc. (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that Dr. David S. Young, President and Chief Executive Officer, received the "Most Innovative" award at the Chinese Canadian Entrepreneur Awards, held on April 5th, 2008 in Toronto, Ontario.

"The FunctionFIRST(TM) antibody discovery platform pioneered by our CEO is the foundation of our company and exemplifies the exceptional innovation that this award honours," said Warren Whitehead, Chief Financial Officer of ARIUS. "As we transition to a clinical company this year, we are proud that ARIUS' mission to generate and develop anti-cancer, antibody drugs has been recognized through this honour."

The Chinese Canadian Entrepreneur Awards, sponsored by the Association of Chinese Canadian Entrepreneurs (ACCE), annually recognizes high achievements by business people and entrepreneurs who have strengthened the competitiveness of Chinese Canadian business community in the global market. The Most Innovative Award is presented to an individual, team of individuals or company who have demonstrated exceptional innovation in their given field and contributed great value to the marketplace.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies.
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
2. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
3. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
4. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
5. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
6. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
7. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
10. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
11. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Dr. Kerry Solomon announce...nd has launched his redesigned website at www.DrK...onsulting Group. Dr. Solomon is a proven LASIK, l...een professionally recognized for his substantial ...ry. He is a member of Trusted LASIK Surgeons, whi...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, C....reportlinker.com/p0164494/Chromium---Global-Marke... is primarily influenced by stainless steel, while...rkets is also important for growth of chromium met...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, Em...Market dynamics and the changing healthcare and re...er.com/p0165658/Emerging-Clinical-Trial-Locations-...healthcare-and-regulatory-environment.html ,, ...
(Date:12/1/2009)..., , CAMBRIDGE, Mass., Dec. 1 /PRNewsw...biology industry and to promote its potential, a g...rmation of the Synthetic Biology Industry Associat.... The goal of the association is to provide a foru...uss the new industry, address its opportunities an...
Breaking Biology Technology:Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
...t. 8 Wyeth Pharmaceuticals, a,division of Wyeth (...ts have,begun for XYNTHA(TM) Antihemophilic Factor...ant factor VIII product for both the,control and p...laxis in,patients with hemophilia A, a rare, inher... using state-of-the-art manufacturing and,purifica...
...wswire-FirstCall/ - Oncolytics Biotech Inc.,("Onco...at that it has,started patient enrolment in a Phas...n of REOLYSIN(R) in combination with paclitaxel an...eck cancers. The Principal,Investigator is Dr. Mon...CTRC) at The University of Texas Health Science Ce...
...rescriber, Software Simplifies Medicare - For Free...,announced the latest release of their PlanPrescri...o longer need to worry about whether they are,gett...ns. PlanPrescriber,the brainchild of MIT Professor... advice to help seniors quickly find their best Me...
Other Biology Technology:New Recombinant XYNTHA Now Available for Patients with Hemophilia A 2New Recombinant XYNTHA Now Available for Patients with Hemophilia A 3New Recombinant XYNTHA Now Available for Patients with Hemophilia A 4New Recombinant XYNTHA Now Available for Patients with Hemophilia A 5Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3On-Line Medicare Advisor Saves Seniors Time, Hassle and Money 2
(Date:12/1/2009)...ased to announce the publication of results from i...acy and tolerability of its novel, intranasal drug...ic rhinosinusitis with nasal polyps in Rhinology ...ropean Rhinologic Societies. , Chronic rhinosin... can significantly reduce a patient,s quality of l...
(Date:12/1/2009)...sity cancer researchers have developed a tumor-at...d blocks the growth of new tumor blood vessels. ,...ll cancer cells oncolytic viruses might be more ...also carry a gene for a protein that inhibits bloo...tin, is normally produced in the brain. In this st...
(Date:12/1/2009)...tacks by sharks can be solved with a new technique...they put on their victims, according to a Universi...a method analogous to analyzing human fingerprints... comparing shark bites to the jaws and teeth of th...r of the International Shark Attack File, which is...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 1Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 1Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 3Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 4If 2 Painkillers Are Banned What Next 3F 50662 1If 2 Painkillers Are Banned What Next 3F 50662 2If 2 Painkillers Are Banned What Next 3F 50662 3If 2 Painkillers Are Banned What Next 3F 50662 4
...entists working in an ice-free region of Antarctic...e form of fossilized plants and insects--on the in...atures began a relentless drop millions of years a... degrees Celsius, over a relatively brief period o...rced the extinction of tundra plants and insects a...
... traditionally focused on protecting individual sp...ring, however, that preserving the benefits that w...ally and environmentally valuable. At the Annual M... ecologists will explore the application of ecosys...tem services are the benefits that humans reap fro...
... professor and Georgia Research Alliance Eminent S...eorgia, has been awarded $9.2 million as part of a...e of General Medical Sciences, part of the Nationa...rtered in the department of biochemistry and molec...ings of the early steps that stem cells take in be...
Other Biology News:Antarctic fossils paint a picture of a much warmer continent 2Antarctic fossils paint a picture of a much warmer continent 3Antarctic fossils paint a picture of a much warmer continent 4Antarctic fossils paint a picture of a much warmer continent 5Evaluating ecosystem services 2Evaluating ecosystem services 3UGA researchers win $9.2 million stem cell grant from NIH 2
...vides complete components including positive and n...DNA fragmentation in cultured cells and tissue sec...optotic cells. Internucleosomal DNA fragmentatio...BLs ApoDIRECT In Situ DNA Fragmentation Assay Kit ...
... , Removes >99% detergent , Very selective, virtu...ple, just pipette, centrifuge and discard pellet ,...hydrophobic chromatography , Detergents can often ...s a simple and fast method to remove SDS and non-i...
EXTRACTI-GEL D from Pierce Biotechnology, Inc.
Solvent-Detergent Removal Resin from Sigma-Aldrich
Biology Products: